1
|
Li S, Chen M, Wang Y, Li X, Gao G, Luo X, Tang L, Liu X, Wu N. An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary Subsolid Nodules Based on Current and Prior CT Scans. Clin Lung Cancer 2023; 24:e301-e310. [PMID: 37596166 DOI: 10.1016/j.cllc.2023.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Revised: 07/30/2023] [Accepted: 08/01/2023] [Indexed: 08/20/2023]
Abstract
INTRODUCTION It is challenging to diagnose and manage incidentally detected pulmonary subsolid nodules due to their indolent nature and heterogeneity. The objective of this study is to construct a decision tree-based model to predict malignancy of a subsolid nodule based on radiomics features and evolution over time. MATERIALS AND METHODS We derived a training set (2947 subsolid nodules), a test set (280 subsolid nodules) from a cohort of outpatient CT scans, and a second test set (5171 subsolid nodules) from the National Lung Cancer Screening Trial (NLST). A Computer-Aided Diagnosis system (CADs) automatically extracted 28 preselected radiomics features, and we calculated the feature change rates as the change of the quantitative measure per time unit between the prior and current CT scans. We built classification models based on XGBoost and employed 5-fold cross validation to optimize the parameters. RESULTS The model that combined radiomics features with their change rates performed the best. The Areas Under Curve (AUCs) on the outpatient test set and on the NLST test set were 0.977 (95% CI, 0.958-0.996) and 0.955 (95% CI, 0.930-0.980), respectively. The model performed consistently well on subgroups stratified by nodule diameters, solid components, and CT scan intervals. CONCLUSION This decision tree-based model trained with the outpatient dataset gives promising predictive performance on the malignancy of pulmonary subsolid nodules. Additionally, it can assist clinicians to deliver more accurate diagnoses and formulate more in-depth follow-up strategies.
Collapse
Affiliation(s)
- Shaolei Li
- Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
| | - Mailin Chen
- Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
| | - Yaqi Wang
- Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
| | - Xiang Li
- Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
| | | | | | - Lei Tang
- Department of Radiology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China
| | | | - Nan Wu
- Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
| |
Collapse
|
2
|
Rajeev-Kumar G, Manjunath R, Gao G, Hasan Y. Interdigitation of Radiation Earlier in the Multimodal Treatment of Patients with Lymphoma: The Effect on Opiate Analgesic Requirements. Int J Radiat Oncol Biol Phys 2023; 117:e482. [PMID: 37785528 DOI: 10.1016/j.ijrobp.2023.06.1705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Delay in radiation therapy (RT) as part of multimodality therapy in Hodgkin (HL) and non-Hodgkin lymphoma (NHL) is associated with worse pain scores. In a heterogeneous cohort of lymphoma patients, we hypothesize that interdigitating RT before fewer (versus more) lines of chemotherapy (C) will be associated with lower opiate analgesic requirement. MATERIALS/METHODS From 2009-2019, patients with HL or NHL received palliative (36.5%) or definitive (63.3%) RT at a single institution. An IRB approved database with baseline treatment/disease characteristics, including oral morphine equivalent (OME) requirement, was reviewed. OME was recorded for a) 3-month period prior to RT, b) the month during RT, and c) 3 months after RT. Post-RT change in OME was calculated as the difference in "b" and "c" such that greater or less OME use post-RT was defined as positive or negative value respectively. We performed one-tailed t-test analyses to determine differences in OME during RT between different cohorts. Correlations between baseline characteristics and OME were performed using Spearman correlations, controlling for lymphoma subtype, stage, tumor volume, relapsed/refractory disease, duration of radiation and bulky disease. RESULTS Of 180 patients, 57.8% had NHL, 40.6% were stage IV and 29.4% had bulky disease. At median of 19 days [6-80] from diagnosis, 74% of patients received C with a median of 2 lines [1-4] before RT. The median interval from diagnosis to RT was 11 months [4-36]. Pearson correlation showed a negative association between time from diagnosis to RT and postRT OME in the definitive cohort (R2 = 0.42, F = 4.54, p = 0.002) such that the longer the time to RT, the larger the decrease in OME postRT as compared to during RT. T-test showed higher mean OME during RT for those receiving > 2 lines of C preRT (148.3mg) as compared to those receiving ≤ 2 lines before RT (51.5mg, p = 0.02). In patients receiving definitive RT, the difference remained significant: those receiving >2 lines of C had higher OME during RT as compared to those receiving ≤ 2 lines (207.5mg versus 48.3mg, p = 0.02). The difference in mean OME for patients receiving >2 C lines versus ≤ 2 lines was not significantly different in the palliative cohort (75.6 vs 60.6, p = 0.33). OME use during RT was also found to be higher in patients with bulky disease as compared to non-bulky disease (175.7 versus 52.0, p = 0.04). CONCLUSION In our single-center experience, patients who received >2 lines of C prior to RT were found to have a significantly higher mean OME requirement during RT. In patients receiving definitive RT, longer time to receipt of RT was found to be associated with a larger decrease in OME post-RT, likely related to starting with a higher OME. Interdigitation of RT early on, prior to the 3rd line of chemotherapy, may help reduce pain and improve quality of life.
Collapse
Affiliation(s)
| | | | - G Gao
- University of Chicago, Chicago, IL
| | - Y Hasan
- Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, IL
| |
Collapse
|
3
|
Lei YN, Li XY, Gao G, Wang WY, Liang ZY, Wang YS. Could immune-related hepatitis rapidly progress to immune-related cirrhosis? Eur Rev Med Pharmacol Sci 2023; 27:1436-1442. [PMID: 36876683 DOI: 10.26355/eurrev_202302_31383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 03/07/2023]
Abstract
BACKGROUND Immune-related hepatitis is one of the prevalent adverse events associated with immunotherapy, especially immune checkpoint inhibitors (ICIs). For patients without a history of liver disease, autoimmune disease, or alcohol consumption, it is not clear whether immune-related hepatitis could rapid progress to immune-related cirrhosis. CASE REPORT We report the case of a 54-year-old female with stage IIIB primary pulmonary lymphoepithelioma-like carcinoma (PLELC) diagnosed with immune-related hepatitis. After 15 months, a liver biopsy demonstrated the rapid progression of liver cirrhosis although systematic corticosteroid administration. CONCLUSIONS Long-term immune activation caused by ICIs may exacerbate the process of cirrhosis. Great attention should be paid to the rapid progression to liver cirrhosis of immune-related hepatitis in the clinic.
Collapse
Affiliation(s)
- Y-N Lei
- Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
| | | | | | | | | | | |
Collapse
|
4
|
Martinez-Navio J, Fuchs S, Mendes D, Muniz CR, Rakasz E, Gao G, Lifson J, Desrosiers R. OP 6.6 – 00134 Viral Suppression in SHIV-infected Rhesus Macaques following AAVmediated Delivery of Closer-to-germline Monoclonal Antibodies. J Virus Erad 2022. [DOI: 10.1016/j.jve.2022.100251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|
5
|
Agarwal R, Bjarnadottir M, Rhue L, Dugas M, Crowley K, Clark J, Gao G. Addressing Algorithmic Bias and the Perpetuation of Health Inequities: An AI Bias Aware Framework. Health Policy and Technology 2022. [DOI: 10.1016/j.hlpt.2022.100702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
|
6
|
Gao G, Chen P, Zhou C, Zhao X, Zhang K, Wu R, Zhang C, Wang Y, Xie Y, Wang Q. Genome-wide association study for reproduction-related traits in Chinese domestic goose. Br Poult Sci 2022; 63:754-760. [PMID: 35775663 DOI: 10.1080/00071668.2022.2096402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
1. This study measured six reproduction traits in a Sichuan white goose population (209 individuals), including fertility, qualified egg rate, plasma concentrations of progesterone (P), follicle-stimulating hormone (FSH), prolactin (PRL) and oestrogen (E2).2. Whole-genome resequencing data from the same goose population (209 individuals) were used in a genome-wide association study (GWAS) utilising a mixed linear model to investigate the genes and genetic markers associated with reproduction traits. The frequency of the selected SNPs and haplotypes were determined using the Matrix-Assisted Laser Desorption Ionisation Time-Of-Flight Mass Spectrometry (MALDI-TOF MS) method.3. In total, 42 SNPs significantly associated with these traits were identified. A haplotype block was constructed based on five SNPs that were significantly associated with qualified egg rate, with individuals having the haplotype CCTTAAGGAA having the lowest qualified egg rate.4. In conclusion, these results provided potential markers for marker-assisted selection to improve goose reproductive performance and a basis for elucidating the genetics of goose reproduction.
Collapse
Affiliation(s)
- G Gao
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Institute of Animal Genetics and Breeding, College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, Sichuan, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - P Chen
- Animal Husbandry and Veterinary Station, Sucheng District Suqian, Jiangsu, P. R. China
| | - C Zhou
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - X Zhao
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - K Zhang
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - R Wu
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - C Zhang
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - Y Wang
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - Y Xie
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| | - Q Wang
- Department of Poultry Science, Chongqing Academy of Animal Science, Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement, Chongqing, P. R. China
| |
Collapse
|
7
|
Wang J, Cheng Y, Wu Y, Cao F, Liu Q, Gao G. 1262TiP Efficacy and safety of consolidative camrelizumab following definitive concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
8
|
Zhou J, Bao M, Gao G, Cai Y, Wu L, Lei L, Zhao J, Ji X, Huang Y, Su C. EP08.01-107 The Increase of Blood Intratumor Heterogeneity Is Associated with Unfavorable Outcomes of ICIs Plus Chemotherapy in NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
9
|
Gao G, Jiang T, Zhou F, Wu F, Li W, Xiong A, Chen X, Ren S, Su C, Hu T, Li Q, Zhu C, Zhou C. EP16.01-005 Cilia-related mRNA Profile Predicts Clinical Response to PD-1 Blockade in Lung Adenocarcinoma. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.1005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Gao G, Cheng L, Zhao C, Li X, Yao C, Li F, You D, Zhou C. EP08.01-035 Personalized ctDNA Detection to Monitor Outcome and Predict Immunotherapy Benefit in Locally Advanced and Metastatic NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
11
|
Cho B, Lee SH, Han JY, Cho E, Lee JS, Lee K, Curtin J, Gao G, Xie J, Schnepp R, Bauml J, Knoblauch R, Thayu M, Kim DW. P1.16-01 Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
12
|
Lv J, Li J, Liu Y, Zhang H, Luo X, Ren M, Gao Y, Ma Y, Liang S, Yang Y, Song Z, Gao G, Gao G, Jiang Y, Li X. Artificial Intelligence-Aided Diagnosis Software to Identify Highly Suspicious Pulmonary Nodules. Front Oncol 2022; 11:749219. [PMID: 35242696 PMCID: PMC8886673 DOI: 10.3389/fonc.2021.749219] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Accepted: 12/17/2021] [Indexed: 12/24/2022] Open
Abstract
Introduction To evaluate the value of artificial intelligence (AI)-assisted software in the diagnosis of lung nodules using a combination of low-dose computed tomography (LDCT) and high-resolution computed tomography (HRCT). Method A total of 113 patients with pulmonary nodules were screened using LDCT. For nodules with the largest diameters, an HRCT local-target scanning program (combined scanning scheme) and a conventional-dose CT scanning scheme were also performed. Lung nodules were subjectively assessed for image signs and compared by size and malignancy rate measured by AI-assisted software. The nodules were divided into improved visibility and identical visibility groups based on differences in the number of signs identified through the two schemes. Results The nodule volume and malignancy probability for subsolid nodules significantly differed between the improved and identical visibility groups. For the combined scanning protocol, we observed significant between-group differences in subsolid nodule malignancy rates. Conclusion Under the operation and decision of AI, the combined scanning scheme may be beneficial for screening high-risk populations.
Collapse
Affiliation(s)
- Jun Lv
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | - Jianhui Li
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | - Yanzhen Liu
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | - Hong Zhang
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | | | - Min Ren
- Tianjin Cardiovascular Institute, Tianjin Chest Hospital, Tianjin, China
| | - Yufan Gao
- Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China
| | - Yanhe Ma
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | - Shuo Liang
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | - Yapeng Yang
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | - Zhenchun Song
- Medical Radiology Department, Tianjin Chest Hospital, Tianjin, China
| | | | - Guozheng Gao
- Pathology Department, Tianjin Chest Hospital, Tianjin, China
| | | | - Ximing Li
- Tianjin Cardiovascular Institute, Tianjin Chest Hospital, Tianjin, China
| |
Collapse
|
13
|
Zhou C, Gao G, Wu L, Wang Z, Chen G, Huang D, Yang Z, Zhou C, Liu L, Li H. 150P Subgroup analysis of ORIENT12: Efficacy of sintilimab in combination with gemcitabine and platinum-based chemotherapy in patients with advanced or metastatic squamous non-small cell lung cancer. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.10.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
14
|
Wang L, Jin YP, Gao G, Wu DY, Zhou XJ, Liu YY, Xia QX. [Clinicopathological features and molecular genetics of Burkitt-like lymphoma with 11q aberration]. Zhonghua Bing Li Xue Za Zhi 2021; 50:655-657. [PMID: 34078056 DOI: 10.3760/cma.j.cn112151-20201228-00980] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Affiliation(s)
- L Wang
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - Y P Jin
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - G Gao
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - D Y Wu
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - X J Zhou
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - Y Y Liu
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - Q X Xia
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| |
Collapse
|
15
|
Han R, Jia Y, Li X, Zhao C, Zhao S, Liu S, Liu Y, Qiao M, Li J, Gao G, Su C, Ren S, Zhou C. P76.07 Metformin Enhances the Efficacy of EGFR-TKIs in Advanced Non-Small Cell Lung Cancer Patients With Type 2 Diabetes Mellitus. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1064] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Zhang P, Gao G, Zhou Z, He X. microRNA-130b downregulation potentiates chondrogenic differentiation of bone marrow mesenchymal stem cells by targeting SOX9. ACTA ACUST UNITED AC 2021; 54:e10345. [PMID: 33624729 PMCID: PMC7894390 DOI: 10.1590/1414-431x202010345] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2020] [Accepted: 10/26/2020] [Indexed: 12/20/2022]
Abstract
Osteoarthritis (OA) is a chronic health condition. MicroRNAs (miRs) are critical in chondrocyte apoptosis in OA. We aimed to investigate the mechanism of miR-130b in OA progression. Bone marrow mesenchymal stem cells (BMSCs) and chondrocytes were first extracted. Chondrogenic differentiation of BMSCs was carried out and verified. Chondrocytes were stimulated with interleukin (IL)-1β to imitate OA condition in vitro. The effect of miR-130b on the viability, inflammation, apoptosis, and extracellular matrix of OA chondrocytes was studied. The target gene of miR-130b was predicted and verified. Rescue experiments were performed to further study the underlying downstream mechanism of miR-130b in OA. miR-130b first increased and drastically reduced during chondrogenic differentiation of BMSCs and in OA chondrocytes, respectively, while IL-1β stimulation resulted in increased miR-130b expression in chondrocytes. miR-130b inhibitor promoted chondrogenic differentiation of BMSCs and chondrocyte growth and inhibited the levels of inflammatory factors. miR-130b targeted SOX9. Overexpression of SOX9 facilitated BMSC chondrogenic differentiation and chondrocyte growth, while siRNA-SOX9 contributed to the opposite trends. Silencing of SOX9 significantly attenuated the pro-chondrogenic effects of miR-130b inhibitor on BMSCs. Overall, miR-130b inhibitor induced chondrogenic differentiation of BMSCs and chondrocyte growth by targeting SOX9.
Collapse
Affiliation(s)
- Penggui Zhang
- The First Department of Orthopedics, Yulin First Hospital, Yulin, Shaanxi, China
| | - Guangming Gao
- The First Department of Orthopedics, Yulin First Hospital, Yulin, Shaanxi, China
| | - Ziyu Zhou
- The First Department of Orthopedics, Yulin First Hospital, Yulin, Shaanxi, China
| | - Xuejun He
- The Second Department of Orthopedics, the First People's Hospital of Xianyang, Xianyang, Shaanxi, China
| |
Collapse
|
17
|
Sinito C, Corfdir P, Pfüller C, Gao G, Bartolomé J, Kölling S, Doblado AR, Jahn U, Lähnemann J, Auzelle T, Zettler JK, Flissikowski T, Koenraad P, Grahn HT, Geelhaar L, Fernández-Garrido S, Brandt O. Correction to Absence of Quantum-Confined Stark Effect in GaN Quantum Disks Embedded in (Al,Ga)N Nanowires Grown by Molecular Beam Epitaxy. Nano Lett 2020; 20:6930. [PMID: 32794760 DOI: 10.1021/acs.nanolett.0c02938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
|
18
|
Gao G, Wang Y, Ren S, Zhao J, Chen G, Chen J, Gu K, Guo R, Pan Y, Wang Q, Zhou C. 1267P Efficacy of camrelizumab (SHR-1210) plus apatinib as second-line treatment for advanced squamous NSCLC. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1581] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
19
|
Wu Q, Zhou Y, Wang Y, Zhang Y, Shen Y, Su Q, Gao G, Xu H, Zhou X, Liu B. Whole-genome sequencing reveals breed-differential CNVs between Tongcheng and Large White pigs. Anim Genet 2020; 51:940-944. [PMID: 32808316 DOI: 10.1111/age.12993] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/24/2020] [Indexed: 01/26/2023]
Abstract
Large phenotypic differences have been observed between Tongcheng and Large White pigs. However, little is known about their genetic basis. This study performed a genome-wide comparison of CNVs between Tongcheng and Large White pigs using genome sequencing data. By combining the advantages of three different strategies (read depth, paired-end mapping and split read), we detected in total 18 687 CNVs that covered approximately 3.5% of the pig genome length for Tongcheng and Large White pigs. We identified 1864 breed-stratified CNVs (top 10%) by performing VST statistics. Functional enrichment analyses for genes located in breed-stratified CNVs were found to be involved in pigmentation, behavior, immune system and reproductive processes, which coincide with phenotypic differences between the two breeds. Using a systematic analysis of the genome and transcriptome data, we further identified four novel breed-differential CNVs on the functional genes (disease-resistant, DCUN1D2 and SPARCL1; lipid metabolism, PLEKHA2 and SLCO1A2). Subsequent PCR validation confirmed their accurate breakpoint positions in 33 Tongcheng pigs and 33 Large White pigs. This study provides essential information on differential CNVs for further research on the genetic basis of phenotypic differences between Tongcheng and Large White pigs.
Collapse
Affiliation(s)
- Q Wu
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - Y Zhou
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - Y Wang
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - Y Zhang
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - Y Shen
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - Q Su
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - G Gao
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - H Xu
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China
| | - X Zhou
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China.,The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, 430070, China
| | - B Liu
- Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, Key Laboratory of Pig Genetics and Breeding of Ministry of Agriculture and College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, 430070, China.,The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, 430070, China
| |
Collapse
|
20
|
Zhang T, Gao G, Chang F. miR-152 promotes spinal cord injury recovery via c-jun amino terminal kinase pathway. Eur Rev Med Pharmacol Sci 2020; 23:44-51. [PMID: 30657545 DOI: 10.26355/eurrev_201901_16746] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE The aim of this research is to explore the possible role of miR-152 in spinal cord injury and its underlying mechanism. MATERIALS AND METHODS After a mouse model of spinal cord injury (SCI) was developed, Real Time-quantitative Polymerase Chain Reaction (RT-qPCR) was used to detect the expression of miR-152 and c-jun in the mouse. In addition, the expression levels of interleukin-1b (IL-1b), interleukin-18 (IL-18) and tumor necrosis factor-α (TNF-α) were detected by enzyme-linked immunosorbent assay (ELISA). Subsequently, miR-152 was overexpressed and the levels of inflammation and c-jun after spinal cord injury were detected by Western blot. Furthermore, the grip strength of double forelimb, left forelimb or right forelimb of the mice was detected using a grip force test after miR-152 was overexpressed in the injured area of each group. RESULTS By constructing a mouse model of spinal cord injury, we found that the expression of miR-152 in the injured area decreased with time; meanwhile, the inflammatory relative genes including IL-1b, IL18, TNF-α, and c-jun were significantly increased. However, miR-152 overexpression significantly reduced the levels of inflammation genes as well as the expression of c-jun. Besides, the strength of the forelimbs in the spinal cord injury mice was restored. CONCLUSIONS MiR-152 could inhibit inflammatory responses and promote the recovery of the spinal cord injury through the c-jun N-terminal kinase pathway and it can be a target molecular for treating spinal cord injury.
Collapse
Affiliation(s)
- T Zhang
- Department of Orthopaedic Surgery, Affiliated Shanxi Provincial People's Hospital, Shanxi Medical University, Taiyuan, China.
| | | | | |
Collapse
|
21
|
Gao G, Wang YZ, Zhang YP, Feng SE, Hou M, Xia QX. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma]. Zhonghua Bing Li Xue Za Zhi 2020; 49:544-549. [PMID: 32486530 DOI: 10.3760/cma.j.cn112151-20191018-00583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the clinicopathological and molecular characteristics of pulmonary enteric adenocarcinoma (PEAC). Methods: The clinical and pathological data of 19 cases of PEAC in the Affiliated Cancer Hospital of Zhengzhou University were retrospectively collected from 2015 to 2019. Immunohistochemistry (IHC) was used to detect the relevant immunophenotypes, amplification refractory mutation system (ARMS) and fluorescence in situ hybridization (FISH) were used to detect the expression of EGFR, KRAS and ALK genes. The patients were followed up, and the relevant literature was reviewed and analyzed. Results: There were 19 cases, including 10 males and 9 females, with a mean age of 58 years (range 33-71 years). Microscopically, the tumors showed moderately to highly differentiated adenoid and/or papillary growth patterns. The tumor cells were highly columnar and sometimes showed pseudostratification. Inflammatory necrosis and scattered nuclear fragmentation were seen in some glandular lumens. IHC showed variable expression of CK7 (19/19), TTF1 (8/19), Napsin A (6/19), villin (17/19), CK20 (16/19) and CDX2 (10/19). Molecular testing showed KRAS mutation in nine cases (9/19), EGFR mutation in one case (1/19), and positive ALK split signal in one case (1/19). In the literature, the reported mutation rate of KRAS in PEAC was much higher than that of EGFR and ALK. All 19 cases underwent surgical resection and 11 cases were subjected to chemotherapy or radiotherapy. Conclusions: PEAC is a rare variant of invasive pulmonary adenocarcinoma, and has similar histological and cytological features to that of colorectal adenocarcinoma. However, detailed medical history, histologic heterogeneity, an IHC combination of CK7(+)/villin(+) and high KRAS mutation rate are the key points of diagnosis. The prognosis needs long-term follow-up and big data statistics.
Collapse
Affiliation(s)
- G Gao
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - Y Z Wang
- Department of Pathology, Shangcheng County People's Hospital, Henan Province, Shangcheng 465350, China
| | - Y P Zhang
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| | - S E Feng
- Department of Pathology, Henan Provincial Hospital, Zhengzhou 451475, China
| | - M Hou
- Department of Pathology, Henan Provincial People's Hospital, Zhengzhou 450008, China
| | - Q X Xia
- Department of Pathology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
| |
Collapse
|
22
|
Gao G, Zhang K, Zhao X, Wu R, Zhong H, Li J, Li C, Xie Y, Wang Q. Molecular cloning of the goose GnRH gene and identification of GnRH polymorphisms associated with laying traits. Br Poult Sci 2020; 61:502-507. [PMID: 32306753 DOI: 10.1080/00071668.2020.1758298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
1. Egg-laying traits are important economic characteristics in goose production (Anser cygnoides). The gene GnRH, which encodes gonadotropin-releasing hormone, is a strong candidate gene for egg-laying traits in avian species. 2. In this study, a 3520 bp genomic sequence and a 279 bp mRNA sequence for GnRH, which encoded 92 amino acids, were determined. The GnRH DNA sequence contains four exons and three introns, and the DNA and deduced amino acid sequences were highly conserved across mammals (human, macaque, cow, and sheep) and avians (chicken, fulmar and quail). 3. Using a direct sequencing method, 46 single nucleotide polymorphisms (SNPs) were identified in the GnRH genomic sequence that were shared between two Sichuan White goose populations (217 and 208 individuals). Furthermore, 44 haplotypes were constructed using a sliding window approach. Association analysis between the SNPs and haplotypes and egg-laying traits showed that 10 SNPs affected the first egg weight, average egg weight, egg number at 48 weeks and egg number at 64 weeks. 4. These results lay the foundation for further studies of the function of GnRH in geese and provide a theoretical basis for marker-assisted selection of egg-laying traits in the Sichuan white goose population.
Collapse
Affiliation(s)
- G Gao
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| | - K Zhang
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| | - X Zhao
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| | - R Wu
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China
| | - H Zhong
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| | - J Li
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| | - C Li
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| | - Y Xie
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| | - Q Wang
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, China.,Poultry Science Department, Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, China
| |
Collapse
|
23
|
Wang Y, Jiang T, Qin Z, Jiang J, Wang Q, Yang S, Rivard C, Gao G, Ng TL, Tu MM, Yu H, Ji H, Zhou C, Ren S, Zhang J, Bunn P, Doebele RC, Camidge DR, Hirsch FR. HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. Ann Oncol 2020; 30:447-455. [PMID: 30596880 DOI: 10.1093/annonc/mdy542] [Citation(s) in RCA: 133] [Impact Index Per Article: 33.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND Effective targeted therapy for non-small-cell lung cancer (NSCLC) patients with human epidermal growth factor receptor 2 (HER2) mutations remains an unmet need. This study investigated the antitumor effect of an irreversible pan-HER receptor tyrosine kinase inhibitor, pyrotinib. PATIENTS AND METHODS Using patient-derived organoids and xenografts established from an HER2-A775_G776YVMA-inserted advanced lung adenocarcinoma patient sample, we investigated the antitumor activity of pyrotinib. Preliminary safety and efficacy of pyrotinib in 15 HER2-mutant NSCLC patients in a phase II clinical trial are also presented. RESULTS Pyrotinib showed significant growth inhibition of organoids relative to afatinib in vitro (P = 0.0038). In the PDX model, pyrotinib showed a superior antitumor effect than afatinib (P = 0.0471) and T-DM1 (P = 0.0138). Mice treated with pyrotinib displayed significant tumor burden reduction (mean tumor volume, -52.2%). In contrast, afatinib (25.4%) and T-DM1 (10.9%) showed no obvious reduction. Moreover, pyrotinib showed a robust ability to inhibit pHER2, pERK and pAkt. In the phase II cohort of 15 patients with HER2-mutant NSCLC, pyrotinib 400 mg resulted in a objective response rate of 53.3% and a median progression-free survival of 6.4 months. CONCLUSION Pyrotinib showed activity against NSCLC with HER2 exon 20 mutations in both patient-derived organoids and a PDX model. In the clinical trial, pyrotinib showed promising efficacy. CLINICAL TRIAL REGISTRATION NCT02535507.
Collapse
Affiliation(s)
- Y Wang
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
| | - T Jiang
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
| | - Z Qin
- Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai
| | - J Jiang
- Department of Medical Affairs, Hengrui Pharmaceutical Company, Shanghai, China
| | - Q Wang
- Department of Medical Affairs, Hengrui Pharmaceutical Company, Shanghai, China
| | - S Yang
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
| | - C Rivard
- Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora
| | - G Gao
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
| | - T L Ng
- Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora
| | - M M Tu
- Department of Surgery (Urology), University of Colorado Anschutz Medical Campus, Aurora; University of Colorado Comprehensive Cancer Center, Aurora
| | - H Yu
- Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora
| | - H Ji
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai; Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai
| | - C Zhou
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
| | - S Ren
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai; Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora.
| | - J Zhang
- Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, USA
| | - P Bunn
- Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora
| | - R C Doebele
- Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora
| | - D R Camidge
- Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora
| | - F R Hirsch
- Departments of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora
| |
Collapse
|
24
|
Zhang K, Gao G, Zhao X, Li Q, Zhong H, Xie Y, Wang Q. The direct effects of gonadotropin-releasing hormone on proliferation of granulosa cells and development of follicles in goose. Br Poult Sci 2020; 61:242-250. [PMID: 32019334 DOI: 10.1080/00071668.2020.1724877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
1. The study objectives were to determine the direct effects of gonadotropin-releasing hormone (GnRH) on the proliferation of ovarian granulosa cells (GCs) and the development of follicles in geese (Anser cygnoides) by colorimetry and ethynyl-2'-deoxyuridine (EdU) cell proliferation assays, in which primary GCs were treated with different concentrations of GnRH agonist (alarelin acetate) and an antagonist (cetrorelix acetate). Differently expressed genes (DEGs) were identified by RNA-sequencing and validated by quantitative reverse transcription polymerase chain reaction (RT-qPCR) and Western blotting. 2. The EdU assays showed that the proliferation of GCs was affected by the GnRH agonist and antagonist in a dose-dependent manner. The effect of treatment on cell proliferation was statistically significant at the concentrations of 10-5 mol/l alarelin and 1 mg/l cetrorelix acetate. A total of 134 DEGs (76 downregulated and 58 upregulated for alarelin treatment) and 226 DEGs (90 downregulated and 136 upregulated for cetrorelix) were identified by RNA-sequencing analysis, respectively. Enrichment analysis indicated that DEGs were enriched in the GO terms of cell-cell signalling and cell junctions. The pathways that regulate the development of follicles were identified, including the biological progress of cAMP accumulation, ovulation cycle and vasculature that are essential to follicular selection. 3. The results suggested that GnRH might directly regulate GC proliferation via autocrine or paracrine pathways related to cell junctions. In particular, it was confirmed that the mRNA and protein expression levels of the oestrogen receptor 2 (ESR2) gene, a negative transcription factor involved in follicular maturation and ovulation, were affected by GnRH agonist or antagonist in GCs. 4. In conclusion, GnRH might play an important role in follicular development by changing the expression of genes that participate in cAMP accumulation, ovulation cycle and cell junctions in ovarian GCs.
Collapse
Affiliation(s)
- K Zhang
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, P. R. China
| | - G Gao
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, P. R. China
| | - X Zhao
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, P. R. China
| | - Q Li
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, P. R. China
| | - H Zhong
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, P. R. China
| | - Y Xie
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, P. R. China
| | - Q Wang
- Poultry Science Department, Chongqing Academy of Animal Science , Chongqing, P. R. China.,Chongqing Engineering Research Center of Goose Genetic Improvement , Chongqing, P. R. China
| |
Collapse
|
25
|
Martinez-Navio J, Desrosiers R, Fuchs S, Mendes D, Rakasz E, Gao G, Lifson J. How long is long-term? Delivery of anti-HIV antibodies using AAV vector. J Virus Erad 2019. [DOI: 10.1016/s2055-6640(20)30202-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
26
|
Chen X, Zhou F, Li X, Zhao C, Li W, Wu F, Yu J, Gao G, Li J, Li A, Ren S, Zhou C. Folate receptor-positive circulating tumour cells as a predictive biomarker for the efficacy of first-line pemetrexed-based therapy in patients with non-squamous non-small cell lung cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz260.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Taylor A, Shih J, Ha G, Gao G, Zhang X, Berger A, Cherniack A, Beroukhim R, Meyerson M. MS12.02 Genomic and Functional Approaches to Understanding Cancer Aneuploidy. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.355] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
28
|
Gao G, Li J, Zhou F, Li W, Xiong A, Chen X, Ren S, Zhou C. P2.04-57 Predictive and Prognostic Value of CTC Monitoring in Advanced NSCLC Patients Treated with Immune Checkpoint Inhibitors. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
29
|
Liu Y, Mao S, Zhou F, Xiong A, Chen B, Yu J, Wu F, He Y, Gao G, Chen X, Su C, Ren S, Zhou C. P2.01-30 Hepatitis B Infection or Aminotransferase Increase Associate with Poor Outcome of Anti-PD-1 Monotherapy in Patients with Advanced NSCLC. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Sinito C, Corfdir P, Pfüller C, Gao G, Bartolomé J, Kölling S, Rodil Doblado A, Jahn U, Lähnemann J, Auzelle T, Zettler JK, Flissikowski T, Koenraad P, Grahn HT, Geelhaar L, Fernández-Garrido S, Brandt O. Absence of Quantum-Confined Stark Effect in GaN Quantum Disks Embedded in (Al,Ga)N Nanowires Grown by Molecular Beam Epitaxy. Nano Lett 2019; 19:5938-5948. [PMID: 31385709 DOI: 10.1021/acs.nanolett.9b01521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Several of the key issues of planar (Al,Ga)N-based deep-ultraviolet light-emitting diodes could potentially be overcome by utilizing nanowire heterostructures, exhibiting high structural perfection, and improved light extraction. Here, we study the spontaneous emission of GaN/(Al,Ga)N nanowire ensembles grown on Si(111) by plasma-assisted molecular beam epitaxy. The nanowires contain single GaN quantum disks embedded in long (Al,Ga)N nanowire segments essential for efficient light extraction. These quantum disks are found to exhibit intense light emission at unexpectedly high energies, namely, significantly above the GaN bandgap, and almost independent of the disk thickness. An in-depth investigation of the actual structure and composition of the nanowires reveals a spontaneously formed Al gradient both along and across the nanowire, resulting in a complex core/shell structure with an Al-deficient core and an Al-rich shell with continuously varying Al content along the entire length of the (Al,Ga)N segment. This compositional change along the nanowire growth axis induces a polarization doping of the shell that results in a degenerate electron gas in the disk, thus screening the built-in electric fields. The high carrier density not only results in the unexpectedly high transition energies but also in radiative lifetimes depending only weakly on temperature, leading to a comparatively high internal quantum efficiency of the GaN quantum disks up to room temperature.
Collapse
Affiliation(s)
- C Sinito
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - P Corfdir
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - C Pfüller
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - G Gao
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - J Bartolomé
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - S Kölling
- Department of Applied Physics , TU Eindhoven , Den Dolech 2 , 5612 Eindhoven , AZ , The Netherlands
| | - A Rodil Doblado
- Department of Applied Physics , TU Eindhoven , Den Dolech 2 , 5612 Eindhoven , AZ , The Netherlands
| | - U Jahn
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - J Lähnemann
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - T Auzelle
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - J K Zettler
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - T Flissikowski
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - P Koenraad
- Department of Applied Physics , TU Eindhoven , Den Dolech 2 , 5612 Eindhoven , AZ , The Netherlands
| | - H T Grahn
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - L Geelhaar
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - S Fernández-Garrido
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| | - O Brandt
- Paul Drude Institut für Festkörperelektronik , Leibniz Institut im Forschungsverbund Berlin e.V. , Hausvogteiplatz 5-7 , 10117 Berlin , Germany
| |
Collapse
|
31
|
Newman H, Jilin H, Zhu B, Bradford L, Gao G. Evaluation of portable colposcopy and HPV testing for screening of cervical cancer in rural China. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.267] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Liu X, Luo L, Yang H, Jie X, Li P, Ma D, Kang Y, Gao G, Luo X, She Y, Li J, Liu Y, Xie W, Lu S, Hu Z, Zhang T. Computer-aided classification of lung nodules on CT scans via 3D CNNs. J Clin Oncol 2019. [DOI: 10.1200/jco.2019.37.15_suppl.e18047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e18047 Background: Computer-aided diagnosis based on deep learning methodologies has demonstrated great potential to assist disease diagnosis with accuracy and efficiency. Specifically, the quantitative and qualitative analysis on lung nodules has proven to be important for the early-detection of lung cancer as well as its treatment in clinical practice. This study developed a 3D CNN model to facilitate the classification of pulmonary nodules. Methods: We collected 3956 lung CT scans (slice thickness≤3mm) with multiple lung nodules from 15 Class-A hospitals in China, 1155 lung CTs from Luna 16 dataset and Data Science Bowl 2017. There were 30 senior radiologists responsible for annotation and each CT scan was annotated by two of them randomly. Another 4 senior associate chief physicians were divided into two groups, each group was responsible for arbitration when conflicts occurred between the annotation doctors. All the annotated CTs were randomly selected and split to construct training, validation and test sets. We pre-processed the CTs and utilized 3D CNNs to classify these nodules as solid, partial-solid, ground glass opacity, calcified, pleural solid and pleural calcified. ROC analysis was used, and the classification capability was assessed by classification accuracy and the AUC score. Results: Table shows the overall results. The proposed model yielded an AUC score of 0.97 for the ground glass opacity and 0.90 for calcified nodules in the training set, while the AUC of them were 0.93 and 0.93 respectively in the validation set. For the test set, we got an AUC score of 0.94 for the ground glass opacity. The average classification time for each nodule was less than 0.005 sec. Conclusions: Our model may assist clinical diagnosis of lung cancer and increase its objectivity and accuracy, and the fast processing speed proves its feasibility to be applied in real clinical practice. In the future, we will enrich the dataset with clinical and genetic information, thus improving our model to boost its performance. [Table: see text]
Collapse
Affiliation(s)
| | - Ligang Luo
- Linkdoc Technology Co., Ltd, Beijing, China
| | - Haiying Yang
- Medical affair, Linkdoc Technology Co., Ltd, Shanghai, China
| | - Xiaoxiang Jie
- Medical Affair, Linkdoc Technology Co., Ltd, Shanghai, China
| | - Peiyu Li
- Medical Affair, Linkdoc Technology Co., Ltd, Shanghai, China
| | - Ding Ma
- Linkdoc Technology Co., Ltd, Beijing, China
| | - Yue Kang
- Linkdoc Technology Co., Ltd, Beijing, China
| | | | | | - Yuli She
- Linkdoc Technology Co., Ltd, Beijing, China
| | - Jinchen Li
- Linkdoc Technology Co., Ltd, Beijing, China
| | - Yuzhe Liu
- Linkdoc Technology Co., Ltd, Beijing, China
| | - Weihao Xie
- Linkdoc Technology Co., Ltd, Beijing, China
| | - Shijie Lu
- Linkdoc Technology Co., Ltd, Beijing, China
| | - Zhongjie Hu
- Medical Affair, Linkdoc Technology Co., Ltd, Beijing, China
| | | |
Collapse
|
33
|
Gao G, Song ZR, Liu HT. [Case report: idiopathic hyperCKemia during pregnancy]. Zhonghua Xin Xue Guan Bing Za Zhi 2019; 47:242-243. [PMID: 30897887 DOI: 10.3760/cma.j.issn.0253-3758.2019.03.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- G Gao
- Department of Cardiology, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China
| | | | | |
Collapse
|
34
|
Calabrese G, Gao G, van Treeck D, Corfdir P, Sinito C, Auzelle T, Trampert A, Geelhaar L, Brandt O, Fernández-Garrido S. Interfacial reactions during the molecular beam epitaxy of GaN nanowires on Ti/Al 2O 3. Nanotechnology 2019; 30:114001. [PMID: 30681980 DOI: 10.1088/1361-6528/aaf9c5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
We investigate the occurrence of interfacial reactions during the self-assembled formation of GaN nanowires on Ti/Al2O3(0001) substrates in plasma-assisted molecular beam epitaxy. The conditions typical for the synthesis of ensembles of long nanowires (>1 μm) are found to promote several chemical reactions. In particular, the high substrate temperature leads to the interdiffusion of Al and O at the Ti/Al2O3 interface resulting in the formation of Al x Ti y O1-x-y and Ti x O1-x compounds. Furthermore, O is found to incorporate into the nanowires degrading their luminescence by heavy n-type doping. At the same time, impinging Ga and N species react with the substrate giving rise to the simultaneous formation of single-crystalline TiN and Ga x Ti y O1-x-y compounds. The latter compounds tend to form hillocks at the substrate surface, on top of which nanowires elongate with large tilt angles with respect to the substrate normal. We develop here a specific process in order to mitigate the detrimental effects of these interfacial reactions, while maintaining the low areal density and absence of coalescence which is the strong asset of growing nanowires on Ti/Al2O3. We find that the combination of a thick Ti film with an intentional low temperature nitridation step preceding nanowire growth and a limited growth temperature results in ensembles of uncoalesced and well-oriented nanowires with luminescence properties comparable to those of standard GaN nanowires prepared on Si. All these properties, together with the inherent benefits of integrating semiconductors on metals, make the present materials combination a promising platform for the further development of group-III nitride nanowire-based devices.
Collapse
Affiliation(s)
- G Calabrese
- Paul-Drude-Institut für Festkörperelektronik, Leibniz-Institut im Forschungsverbund Berlin e.V., Hausvogteiplatz 57, D-10117 Berlin, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
|
36
|
|
37
|
Wu F, Gao G, Zhou C, Kang X, Zhou Y. A phase III, randomized, open-label, multicenter study of SHR-1210 (anti-PD-1 antibody) in combination with pemetrexed and carboplatin as first line therapy in subjects with advanced/metastatic non-squamous non-small cell lung cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.126] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Yin Q, Gao G, Zhou C, Liu Y, Xie X, Lin X, Zhu Z, Xie Z, Zhang J, Ming O, Chen R, Li S. P2.01-111 Clinical Features and Prognosis of Eighty-Five Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
39
|
Higgs B, Morehouse C, Brohawn P, Sridhar S, Raja R, Gao G, Englert J, Ranade K. High tumor mutational burden (TMB) and PD-L1 have similar predictive utility in 2L+ NSCLC patients (pts) treated with anti-PD-L1 and anti-CTLA-4. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy269.063] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Massard C, Segal N, Cho D, Papadimitrakopoulou V, Rizvi N, Cho B, Yu L, Yang H, Hsieh HJ, Zhang J, Zhao W, Gao G, Guo X, Abdullah S, Englert J, Soria JC, Dar M, Roskos L, Ferte C, Antonia S. Prospective validation of prognostic scores to improve patient selection for immuno-oncology trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy279.426] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
41
|
Zhao S, Jia Y, Jiang T, Li X, Li W, Gao G, Zhao C, He Y, Chen X, Su C, Ren S, Zhou C. P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-PD-(L)1 Immunotherapies in Chinese Patients with Advanced Non-Small Cell Lung Cancer. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1728] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
42
|
Liu QY, Gao G, Hu GM, Feng SE, Zhang YP, Jia EC, Li DG, Zhao YW. [Clinicopathologic and molecular subtyping analysis of occult breast cancer]. Zhonghua Bing Li Xue Za Zhi 2018; 47:633-634. [PMID: 30107672 DOI: 10.3760/cma.j.issn.0529-5807.2018.08.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
|
43
|
Liu QY, Zhang YP, Xu ZG, Gao G, Feng SE, Kong LF, Wang YG. [Clinicopathologic and genetic features analysis of oral and maxillofacial metastatic carcinoma]. Zhonghua Bing Li Xue Za Zhi 2018; 47:546-547. [PMID: 29996323 DOI: 10.3760/cma.j.issn.0529-5807.2018.07.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
|
44
|
Deng LL, Deng HB, Lu CL, Gao G, Wang F, Yang Y. Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma. Clin Transl Oncol 2018; 21:197-205. [DOI: 10.1007/s12094-018-1906-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Accepted: 06/01/2018] [Indexed: 12/26/2022]
|
45
|
Gao G, Qian MH, Ji C, Yao M. [The analysis of the effect of psycho-intervention combined with diazepam on patients with sudden sensorineural hearing loss and anxiety]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018; 32:753-757. [PMID: 29873212 DOI: 10.13201/j.issn.1001-1781.2018.10.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 02/01/2018] [Indexed: 11/12/2022]
Abstract
Objective: To investigate the therapeutic effect of psychological intervention combined with diazepam on sudden hearing loss patients with anxiety. Method: 108 cases of sudden hearing loss patients with anxiety were randomly divided into two groups(n=54 in each group): The control group received routine treatment of sudden hearing loss, the study group was given psychological intervention combined with diazepam tablets(2.5 mg once, twice a day) based on the routine treatment. The hearing and HAMA and SAS scores were reviewed after 10 days of treatment. Result: After 10 days of treatment, the average hearing threshold of patients in the control group and the study group were respectively increased by (19.65±7.89)dB and (26.93±9.04)dB (t=4.54, P=0.006), the HAMA score of two groups were respectively decreased by 4.68 and 10.75(t=9.949, P=0.000)and the SAS score of two groups were respectively decreased by 15.93 and 23.39 (t=6.773, P=0.000), and the total efficiency of hearing of two groups were 61.11% and 77.78% (χ²=4.441, P=0.035),respectively. the differences were statistically significant. Conclusion: Psychological intervention combined with diazepam can relieve anxiety in patients with sudden hearing loss effectively, and play a positive role in the development and prognosis of patients with sudden sensorineural hearing loss.
Collapse
Affiliation(s)
- G Gao
- Department of Otorhinolaryngology, the Second Affilicated Hospital of Nantong University, Nantong, 226001, China
| | - M H Qian
- Department of Otorhinolaryngology, the Second Affilicated Hospital of Nantong University, Nantong, 226001, China
| | - C Ji
- Department of Otorhinolaryngology, the Second Affilicated Hospital of Nantong University, Nantong, 226001, China
| | - M Yao
- Department of Otorhinolaryngology, the Second Affilicated Hospital of Nantong University, Nantong, 226001, China
| |
Collapse
|
46
|
Lv J, Zhang H, Ma J, Ma Y, Gao G, Song Z, Yang Y. Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomas. Clin Radiol 2018; 73:590.e1-590.e8. [DOI: 10.1016/j.crad.2018.01.009] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Accepted: 01/11/2018] [Indexed: 01/26/2023]
|
47
|
Jiang WG, Ye L, Owen S, Ruge F, Martin TA, Sanders AJ, Gao G, Wei C, Wu Y, Davies E. Abstract P3-15-04: Signalling pathways targeted by the YangZheng Xiaoji extract and the therapeutic implications in human breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p3-15-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background. Yangzheng Xiaoji is a formulation of Chinese medicine and has been used in the treatment of solid cancer as an adjuvant to chemotherapy by reducing the side effects to the patient. There has been evidence to show that the medicine has a direct biological role in cancer cells. In the present study, we sought to investigate the potential effects of the medicine on breast cancer cells and in particular aimed to identify the key targets and molecular pathways contributing to the anti-cancer effect of the medicine.
Methods. Human breast cancer cell lines (BT549, BT20, MDA MB-231, MCF-7 and ZR 75-1) with varying invasiveness and receptor status were used. The soluble extract of Yangzheng Xiaoji, namely DME25 was used in the study. The effects of DME25 on the growth, toxicity and cellular migration were assessed. Signalling kinase changes were screened using kinase antibody array based array technologies. Kinases were also validated using phosphorylation based protein blotting.
Results. Of the five breast cancer cell lines tested, Yangzheng Xiaoji extract DME25 showed little cytotoxicity over a broad range of concentrations. However, DME25 were able to markedly reduce the migration of the panel of breast cancer tested, without being toxic. Triple negative cells responded in a similar fashion with other cells. It was also noted that the adhesion of these cells were also inhibited by DME25. Using a protein kinase array, it was shown that a number of kinase complexes were inhibited by the medicine, notable ones including EGFR family kinases (reduced by 35%), Janus protein kinases (JAK) (by 57%), and Ras-related C3 botulinum toxin substrate (Rac1 or CDC42 GTPase) (by 49%) and Ribosomal protein S6 kinases (RSKs) (by 52%). Given the clinical significance of RSKs in human breast cancer, we further evaluated the role of RSK and RSK inhibitors in DME mediated cell functions and have demonstrated that both in triple negative breast cancer cells and receptor positive breast cancer cell lines, DME25 was able to synergistically enhance the effect of RSK2 inhibitor, SL1010-1, on the both the cellular migration and cell growth.
Conclusion. Yangzheng Xiaoji has a broad and direct effect on the migration of breast cancer, an effect unrelated to hormone receptor status and independent of cytotoxicity. The medicine appears to target kinase pathway, particularly for the RSK kinases, suggesting an important clinical implication in the treatment of breast cancer.
Citation Format: Jiang WG, Ye L, Owen S, Ruge F, Martin TA, Sanders AJ, Gao G, Wei C, Wu Y, Davies E. Signalling pathways targeted by the YangZheng Xiaoji extract and the therapeutic implications in human breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P3-15-04.
Collapse
Affiliation(s)
- WG Jiang
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - L Ye
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - S Owen
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - F Ruge
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - TA Martin
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - AJ Sanders
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - G Gao
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - C Wei
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - Y Wu
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| | - E Davies
- Cardiff University School of Medicine, Cardiff, Wales, United Kingdom; Yiling Pharmaceuticals, Cardiff, Hebei Province, China; Breast Cancer Centre, University Llandough Hospital, Cardiff, Wales, United Kingdom
| |
Collapse
|
48
|
Koppel S, Charlton JL, Hua P, Liu PY, Pham H, Stephan K, Logan D, St Louis RM, Gao G, Griffiths D, Williams G, Witharanage T, Di Stefano M, Darzins P, Odell M, Porter MM, Mazer B, Gelinas I, Vrkljan B, Marshall S. Are older drivers' driving patterns during an on-road driving task representative of their real-world driving patterns? Traffic Inj Prev 2018; 19:S173-S175. [PMID: 30841798 DOI: 10.1080/15389588.2018.1532219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
OBJECTIVE The current study investigated whether older drivers' driving patterns during a customized on-road driving task were representative of their real-world driving patterns. METHODS Two hundred and eight participants (male: 68.80%; mean age = 81.52 years, SD = 3.37 years, range = 76.00-96.00 years) completed a customized on-road driving task that commenced from their home and was conducted in their own vehicle. Participants' real-world driving patterns for the preceding 4-month period were also collected via an in-car recording device (ICRD) that was installed in each participant's vehicle. RESULTS During the 4-month period prior to completing the on-road driving task, participants' median real-world driving trip distance was 2.66 km (interquartile range [IQR] = 1.14-5.79 km) and their median on-road driving task trip distance was 4.41 km (IQR = 2.83-6.35 km). Most participants' on-road driving task trip distances were classified as representative of their real-world driving trip distances (95.2%, n = 198). CONCLUSIONS These findings suggest that most older drivers were able to devise a driving route that was representative of their real-world driving trip distance. Future research will examine whether additional aspects of the on-road driving task (e.g., average speed, proportion of trips in different speed zones) are representative of participants' real-world driving patterns.
Collapse
Affiliation(s)
- S Koppel
- a Monash University Accident Research Centre , Victoria , Australia
| | - J L Charlton
- a Monash University Accident Research Centre , Victoria , Australia
| | - P Hua
- a Monash University Accident Research Centre , Victoria , Australia
| | - P Y Liu
- a Monash University Accident Research Centre , Victoria , Australia
| | - H Pham
- a Monash University Accident Research Centre , Victoria , Australia
| | - K Stephan
- a Monash University Accident Research Centre , Victoria , Australia
| | - D Logan
- a Monash University Accident Research Centre , Victoria , Australia
| | - R M St Louis
- a Monash University Accident Research Centre , Victoria , Australia
| | - G Gao
- a Monash University Accident Research Centre , Victoria , Australia
| | - D Griffiths
- a Monash University Accident Research Centre , Victoria , Australia
| | - G Williams
- a Monash University Accident Research Centre , Victoria , Australia
| | - T Witharanage
- a Monash University Accident Research Centre , Victoria , Australia
| | | | - P Darzins
- c Eastern Health , Victoria, Australia
| | - M Odell
- d Victorian Institute of Forensic Medicine , Victoria, Australia
| | - M M Porter
- e Faculty of Kinesiology and Recreation Management, and Centre on Aging , University of Manitoba , Canada
| | - B Mazer
- f McGill University , Winnipeg, Canada
| | - I Gelinas
- f McGill University , Winnipeg, Canada
| | - B Vrkljan
- g McMaster University , Hamilton, Canada
| | - S Marshall
- h Ottawa Hospital Research Institute , Ottawa, Canada
| |
Collapse
|
49
|
Yang L, Zha Y, Feng J, Dong H, Zong C, Lei X, Liang N, Wang X, Gao G, Bai X. Treatment of a Pediatric Case of Severe Hemorrhagic Cystitis: Case Report and Review of Literature. Transplant Proc 2017; 49:2365-2367. [PMID: 29198679 DOI: 10.1016/j.transproceed.2017.10.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2017] [Accepted: 10/04/2017] [Indexed: 11/16/2022]
Abstract
Hemorrhagic cystitis is one of the complications of allogeneic hematopoietic stem cell transplantation. Treatment of hemorrhagic cystitis is difficult, especially in pediatric patients. A pediatric case of severe hemorrhagic cystitis after hematopoietic stem cell transplantation was treated in our hospital with arterial embolization combined with corticosteroid therapy because the conventional therapy was invalid for him. After the treatment, hemorrhagic cystitis was cured. During follow-up, the patient was in stable condition, with normal urine, blood cells returned to normal, bone marrow was in complete remission state, and disease-free survival for more than 8 months. Selective bladder arterial embolism followed by corticosteroid therapy successfully treated the patient.
Collapse
Affiliation(s)
- L Yang
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - Y Zha
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - J Feng
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - H Dong
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - C Zong
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - X Lei
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - N Liang
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - X Wang
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - G Gao
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China
| | - X Bai
- Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
| |
Collapse
|
50
|
He Y, Zhao C, Li X, Ren S, Jiang T, Zhang J, Su C, Chen X, Cai W, Gao G, Li W, Wu F, Li J, Zhao J, Zhou F, Hu Q, Hirsch F, Zhou C. P1.03-052 Comparing EGFR-TKI with EGFR-TKI plus Chemotherapy as 1st Line Treatment in Advanced NSCLC Patients with Both Mutated EGFR and Bim Polymorphism. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|